Screener
CapEx at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| (in thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of investments | — | (122,547) |
| Sales and maturities of investments | 35,000 | 137,429 |
| Purchases of property and equipment | (17) | (35) |
| Net cash provided by investing activities | 34,983 | 14,847 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Net parent investment | 7,851 | 5,716 |
| Net cash provided by financing activities | 7,851 | 5,716 |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's capex?
- First Tracks Biotherapeutics Inc (TRAX) reported capex of $17K in Q1 2026.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about First Tracks Biotherapeutics Inc's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude